США - англійська - NLM (National Library of Medicine)

paramesh banerji life sciences llc - plantago 1x hpus - treats toothache treats toothache

США - англійська - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) - ear & toothache condition listed above or as directed by the physician

США - англійська - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) - ear & toothache condition listed above or as directed by the physician

США - англійська - NLM (National Library of Medicine)

boiron - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) - children bedwetting or dental pains* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

США - англійська - NLM (National Library of Medicine)

boiron - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) - children bedwetting or dental pains* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

США - англійська - NLM (National Library of Medicine)

boiron - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) - children bedwetting or dental pains* stop use and ask a doctor if symptoms persist for more than 3 days or worsen

Бельгія - англійська - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

therabel pharma sa-nv - plantago lanceolata l., leaf, fluid extract ethanol 25% 1_1 101,2 mg/ml - syrup - plantago lanceolata l., leaf, fluid extract ethanol 25% 1_1 101.2 mg/ml - cough suppressants, excl. combinations with expectorants

США - англійська - NLM (National Library of Medicine)

hahnemann laboratories, inc. - plantago major (unii: w2469wno6u) (plantago major - unii:w2469wno6u) -

США - англійська - NLM (National Library of Medicine)

alk-abello, inc. - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), agrostis gigantea pollen (unii: hu8v6e7hoa) (agrostis gigantea pollen - unii:hu8v6e7hoa), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y) - phleum pratense pollen 1000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w

США - англійська - NLM (National Library of Medicine)

alk-abello, inc. - dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p) - dactylis glomerata pollen 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust mites, molds, animal danders, and various other inhalants, in situations where the offending allergen cannot be avoided. prior to the initiation of therapy, clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided. a patient should not be immunized against a substance which the patient has not demonstrated symptoms and/or tissue-fixed ige antibodies as demonstrated by skin testing. immunotherapy should not be attempted in patients with active asthma, severe respiratory obstruction, or cardiovascular disease. there is some evidence, although inconclusive, that routine immunizations may exacerbate autoimmune diseases. hyposensitization should be given cautiously to patients with this predisposition. the physician must w